368 related articles for article (PubMed ID: 26969684)
1. Is Huntington's disease a tauopathy?
Gratuze M; Cisbani G; Cicchetti F; Planel E
Brain; 2016 Apr; 139(Pt 4):1014-25. PubMed ID: 26969684
[TBL] [Abstract][Full Text] [Related]
2. The role of tau in the pathological process and clinical expression of Huntington's disease.
Vuono R; Winder-Rhodes S; de Silva R; Cisbani G; Drouin-Ouellet J; ; Spillantini MG; Cicchetti F; Barker RA
Brain; 2015 Jul; 138(Pt 7):1907-18. PubMed ID: 25953777
[TBL] [Abstract][Full Text] [Related]
3. Spectrum of tau pathologies in Huntington's disease.
Baskota SU; Lopez OL; Greenamyre JT; Kofler J
Lab Invest; 2019 Jul; 99(7):1068-1077. PubMed ID: 30573872
[TBL] [Abstract][Full Text] [Related]
4. Tauopathies: classification and clinical update on neurodegenerative diseases associated with microtubule-associated protein tau.
Williams DR
Intern Med J; 2006 Oct; 36(10):652-60. PubMed ID: 16958643
[TBL] [Abstract][Full Text] [Related]
5. Mutant huntingtin alters Tau phosphorylation and subcellular distribution.
Blum D; Herrera F; Francelle L; Mendes T; Basquin M; Obriot H; Demeyer D; Sergeant N; Gerhardt E; Brouillet E; Buée L; Outeiro TF
Hum Mol Genet; 2015 Jan; 24(1):76-85. PubMed ID: 25143394
[TBL] [Abstract][Full Text] [Related]
6. Huntington's disease is a four-repeat tauopathy with tau nuclear rods.
Fernández-Nogales M; Cabrera JR; Santos-Galindo M; Hoozemans JJ; Ferrer I; Rozemuller AJ; Hernández F; Avila J; Lucas JJ
Nat Med; 2014 Aug; 20(8):881-5. PubMed ID: 25038828
[TBL] [Abstract][Full Text] [Related]
7. Faulty splicing and cytoskeleton abnormalities in Huntington's disease.
Fernández-Nogales M; Santos-Galindo M; Hernández IH; Cabrera JR; Lucas JJ
Brain Pathol; 2016 Nov; 26(6):772-778. PubMed ID: 27529534
[TBL] [Abstract][Full Text] [Related]
8. Invited review: Neuropathology of tauopathies: principles and practice.
Kovacs GG
Neuropathol Appl Neurobiol; 2015 Feb; 41(1):3-23. PubMed ID: 25495175
[TBL] [Abstract][Full Text] [Related]
9. Tau hyperphosphorylation and deregulation of calcineurin in mouse models of Huntington's disease.
Gratuze M; Noël A; Julien C; Cisbani G; Milot-Rousseau P; Morin F; Dickler M; Goupil C; Bezeau F; Poitras I; Bissonnette S; Whittington RA; Hébert SS; Cicchetti F; Parker JA; Samadi P; Planel E
Hum Mol Genet; 2015 Jan; 24(1):86-99. PubMed ID: 25205109
[TBL] [Abstract][Full Text] [Related]
10. Genetic forms of tauopathies: inherited causes and implications of Alzheimer's disease-like TAU pathology in primary and secondary tauopathies.
Langerscheidt F; Wied T; Al Kabbani MA; van Eimeren T; Wunderlich G; Zempel H
J Neurol; 2024 Jun; 271(6):2992-3018. PubMed ID: 38554150
[TBL] [Abstract][Full Text] [Related]
11. Threonine
Moszczynski AJ; Yang W; Hammond R; Ang LC; Strong MJ
Acta Neuropathol Commun; 2017 Jan; 5(1):6. PubMed ID: 28077166
[TBL] [Abstract][Full Text] [Related]
12. Loss-of-function and gain-of-function studies refute the hypothesis that tau protein is causally involved in the pathogenesis of Huntington's disease.
Mees I; Li S; Beauchamp LC; Barnham KJ; Dutschmann M; Hannan AJ; Renoir T
Hum Mol Genet; 2022 Jun; 31(12):1997-2009. PubMed ID: 34999772
[TBL] [Abstract][Full Text] [Related]
13. [Neuropathology of tauopathy].
Yoshida M
Brain Nerve; 2013 Dec; 65(12):1445-58. PubMed ID: 24323931
[TBL] [Abstract][Full Text] [Related]
14. Passive immunization against phosphorylated tau improves features of Huntington's disease pathology.
Alpaugh M; Masnata M; de Rus Jacquet A; Lepinay E; Denis HL; Saint-Pierre M; Davies P; Planel E; Cicchetti F
Mol Ther; 2022 Apr; 30(4):1500-1522. PubMed ID: 35051614
[TBL] [Abstract][Full Text] [Related]
15. Glial and neuronal tau pathology in tauopathies: characterization of disease-specific phenotypes and tau pathology progression.
Ferrer I; López-González I; Carmona M; Arregui L; Dalfó E; Torrejón-Escribano B; Diehl R; Kovacs GG
J Neuropathol Exp Neurol; 2014 Jan; 73(1):81-97. PubMed ID: 24335532
[TBL] [Abstract][Full Text] [Related]
16. Expression of the small heat-shock protein alphaB-crystallin in tauopathies with glial pathology.
Dabir DV; Trojanowski JQ; Richter-Landsberg C; Lee VM; Forman MS
Am J Pathol; 2004 Jan; 164(1):155-66. PubMed ID: 14695329
[TBL] [Abstract][Full Text] [Related]
17. Increased pro-nerve growth factor and decreased brain-derived neurotrophic factor in non-Alzheimer's disease tauopathies.
Belrose JC; Masoudi R; Michalski B; Fahnestock M
Neurobiol Aging; 2014 Apr; 35(4):926-33. PubMed ID: 24112788
[TBL] [Abstract][Full Text] [Related]
18. Patterns of hippocampal tau pathology differentiate neurodegenerative dementias.
Milenkovic I; Petrov T; Kovacs GG
Dement Geriatr Cogn Disord; 2014; 38(5-6):375-88. PubMed ID: 25195847
[TBL] [Abstract][Full Text] [Related]
19. Tauopathies.
Kovacs GG
Handb Clin Neurol; 2017; 145():355-368. PubMed ID: 28987182
[TBL] [Abstract][Full Text] [Related]
20. Presence of tau pathology within foetal neural allografts in patients with Huntington's and Parkinson's disease.
Cisbani G; Maxan A; Kordower JH; Planel E; Freeman TB; Cicchetti F
Brain; 2017 Nov; 140(11):2982-2992. PubMed ID: 29069396
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
